|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000294,
umls-concept:C0020823,
umls-concept:C0025519,
umls-concept:C0030705,
umls-concept:C0079460,
umls-concept:C0201734,
umls-concept:C0205179,
umls-concept:C0205210,
umls-concept:C0241315,
umls-concept:C0549178,
umls-concept:C1257890,
umls-concept:C1261473,
umls-concept:C1516225
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-2-1
|
|
pubmed:abstractText |
The aim of this study was to assess the pharmacology, toxicity and activity of high-dose ifosfamide mesna +/- GM-CSF administered by a five-day continuous infusion at a total ifosfamide dose of 12-18 g/m2 in adult patients with advanced sarcomas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1087-94
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10572607-Adult,
pubmed-meshheading:10572607-Aged,
pubmed-meshheading:10572607-Antineoplastic Agents, Alkylating,
pubmed-meshheading:10572607-Area Under Curve,
pubmed-meshheading:10572607-Dose-Response Relationship, Drug,
pubmed-meshheading:10572607-Female,
pubmed-meshheading:10572607-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:10572607-Humans,
pubmed-meshheading:10572607-Ifosfamide,
pubmed-meshheading:10572607-Male,
pubmed-meshheading:10572607-Mesna,
pubmed-meshheading:10572607-Middle Aged,
pubmed-meshheading:10572607-Prodrugs,
pubmed-meshheading:10572607-Protective Agents,
pubmed-meshheading:10572607-Remission Induction,
pubmed-meshheading:10572607-Sarcoma,
pubmed-meshheading:10572607-Time Factors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK).
|
|
pubmed:affiliation |
Department of Oncology, Kantonsspital, St. Gallen, Switzerland. mcca@msl.kssg.ch
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
